It is a pharma private limited company based in Madurai, Tamil Nadu, India, established in 1989.
1989 | Madurai, Tamil Nadu, India | ActiveLotus Drugs Private Limited, a active private limited company, was established on 27 December 1989 in Madurai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231TN1989PTC018519. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.18 M.
It upholds a compliant status. Its leadership includes Laguduva Gopalachari Dhuvaraganath (Director), Shanmugam Chidambaram (Director), Kannan Arun (Director). Past directors included Kumarasamy Kannan, Gopalakrishnan Balaji, Kannan Arun. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 89 - A, East Veli Street Upstairs, Madurai, Tamil Nadu, 625001.
U24231TN1989PTC018519
018519
27 December 1989
₹2.00 M
₹0.18 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Lotus Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Laguduva Gopalachari Dhuvaraganath | Director | 31 May 2006 | Current |
| Shanmugam Chidambaram | Director | 31 May 2006 | Current |
| Kannan Arun | Director | 10 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Nov 2017 | Past |
| Pramod Abcsdd | Director | 23 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 11 Sep 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lotus Drugs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Lotus Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 1996 | State Bank Of India | ₹0.70 M | Open |
| 28 Mar 1994 | State Bank Of India | ₹0.20 M | Open |
| 03 Apr 1991 | Canara Bank | ₹0.10 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lotus Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lotus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lotus Drugs Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
Lotus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Chennai. was recorded as a recent event.
The activity Kannan Arun was appointed as a Director was appointed as a Director on 10 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
Laguduva Gopalachari Dhuvaraganath was appointed as a Director was appointed as a Director on 31 May 2006 & has been associated with this company since 19 years 6 months . was recorded as a recent event.
Progress on Shanmugam Chidambaram was appointed as a Director was appointed as a Director on 31 May 2006 & has been associated with this company since 19 years 6 months . was documented.
A charge with State Bank Of India amounted to Rs. 0.70 M with Charge ID 90307629 was registered on 15 Oct 1996. was recorded as a recent event.
The CIN of Lotus Drugs Private Limited is U24231TN1989PTC018519.
Lotus Drugs Private Limited is headquartered at 89 - A, East Veli Street Upstairs, Madurai, Tamil Nadu, 625001.
Lotus Drugs Private Limited was incorporated on 27 December 1989.
The current directors of Lotus Drugs Private Limited are
The primary industry of Lotus Drugs Private Limited is Manufacturing.
Lotus Drugs Private Limited is unlisted.
The authorized capital of Lotus Drugs Private Limited is ₹2.00 M, and the paid-up capital is ₹0.18 M.
The compliance status of Lotus Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX